Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2012

Open Access 01-12-2012 | Research

Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: Which differences are clinically important?

Authors: Ilya Adamchic, Peter Alexander Tass, Berthold Langguth, Christian Hauptmann, Michael Koller, Martin Schecklmann, Florian Zeman, Michael Landgrebe

Published in: Health and Quality of Life Outcomes | Issue 1/2012

Login to get access

Abstract

Background

Development of new tinnitus treatments requires prospective placebo-controlled randomized trials to prove their efficacy. The Tinnitus Questionnaire (TQ) is a validated and commonly used instrument for assessment of tinnitus severity and has been used in many clinical studies. Defining the Minimal Clinically Important Difference (MCID) for TQ changes is an important step to a better interpretation of the clinical relevance of changes observed in clinical trials. In this study we aimed to estimate the minimum change of the TQ score that could be considered clinically relevant.

Methods

757 patients with chronic tinnitus were pooled from the TRI database and the RESET study. An anchor-based approach using the Clinical Global Impression (CGI) scale and distributional approaches were used to estimate MCID. Receiver Operating Characteristic (ROC) curves were calculated to define optimal TQ change cutoffs discriminating between minimally changed and unchanged subjects.

Results

The relationship between TQ change scores and CGI ratings of change was good (r = 0.52, p < 0.05). Mean change scores associated with minimally better and minimally worse CGI categories were −6.65 and +2.72 respectively. According to the ROC method MCID for improvement was −5 points and for deterioration +1 points.

Conclusion

Distribution and anchor-based methods yielded comparable results in identifying MCIDs. ΔTQ scores of −5 and +1 points were identified as the minimal clinically relevant change for improvement and worsening respectively. The asymmetry of the MCIDs for improvement and worsening may be related to expectation effects.
Appendix
Available only for authorised users
Literature
1.
2.
Weisz N, Moratti S, Meinzer M, Dohrmann K, Elbert T: Tinnitus perception and distress is related to abnormal spontaneous brain activity as measured by magnetoencephalography. PLoS Med 2005, 2: e153. 10.1371/journal.pmed.0020153PubMedCentralCrossRefPubMed
3.
Hoare DJ, Kowalkowski VL, Kang S, Hall DA: Systematic review and meta-analyses of randomized controlled trials examining tinnitus management. Laryngoscope 2011, 121: 1555–1564. 10.1002/lary.21825PubMedCentralCrossRefPubMed
4.
Noble W: Self-assessment of hearing and related functions. Whurr 1998.
5.
6.
Noreña A: Changes in spontaneous neural activity immediately after an acoustic trauma: implications for neural correlates of tinnitus. Hear Res 2003, 183: 137–153. 10.1016/S0378-5955(03)00225-9CrossRefPubMed
7.
van der Loo E, Gais S, Congedo M, Vanneste S, Plazier M, Menovsky T, Van de Heyning P, De Ridder D: Tinnitus intensity dependent gamma oscillations of the contralateral auditory cortex. PLoS One 2009, 4: e7396. 10.1371/journal.pone.0007396PubMedCentralCrossRefPubMed
8.
Schlee W, Hartmann T, Langguth B, Weisz N: Abnormal resting-state cortical coupling in chronic tinnitus. BMC Neurosci 2009, 10: 11. 10.1186/1471-2202-10-11PubMedCentralCrossRefPubMed
9.
Landgrebe M, Binder H, Koller M, Eberl Y, Kleinjung T, Eichhammer P, Graf E, Hajak G, Langguth B: Design of a placebo-controlled, randomized study of the efficacy of repetitive transcranial magnetic stimulation for the treatment of chronic tinnitus. BMC Psychiatry 2008, 8: 23. 10.1186/1471-244X-8-23PubMedCentralCrossRefPubMed
10.
De Ridder D, De Mulder G, Menovsky T, Sunaert S, Kovacs S: Electrical stimulation of auditory and somatosensory cortices for treatment of tinnitus and pain. Prog Brain Res 2007, 166: 377–388.CrossRefPubMed
11.
Dohrmann K, Weisz N, Schlee W, Hartmann T, Elbert T: Neurofeedback for treating tinnitus.. 2007, 166: 473–554.
12.
Langguth B, Landgrebe M, Kleinjung T, Sand GP, Hajak G: Tinnitus and depression. World J Biol Psychiatry 2011, 12: 489–500. 10.3109/15622975.2011.575178CrossRefPubMed
13.
Langguth B, Goodey R, Azevedo A, Bjorne A, Cacace A, Crocetti A, Del Bo L, De Ridder D, Diges I, Elbert T, et al.: Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006. In In Tinnitus: Pathophysiology and Treatment. Volume 166. Edited by: Langguth B, Hajak G, Kleinjung T, Cacace A, Moller AR. Elsevier Science Bv, Amsterdam; 2007:525–536. Progress in Brain ResearchCrossRef
14.
Hallam RS, Jakes SC, Hinchcliffe R: Cognitive variables in tinnitus annoyance. Br J Clin Psychol 1988, 27(Pt 3):213–222.CrossRefPubMed
15.
Goebel G, Hiller W: Tinnitus-Fragebogen: ein Instrument zur Erfassung von Belastung und Schweregrad bei Tinnitus. Hogrefe, Verl. für Psychologie 1998.
16.
Kuk FK, Tyler RS, Russell D, Jordan H: The Psychometric Properties of a Tinnitus Handicap Questionnaire. Ear Hear 1990, 11: 434–445. 10.1097/00003446-199012000-00005CrossRefPubMed
17.
Wilson PH, Henry J, Bowen M, Haralambous G: Tinnitus Reaction Questionnaire - Psychometric Properties of a Measure of Distress Associated with Tinnitus. J Speech Hear Res 1991, 34: 197–201.CrossRefPubMed
18.
Flor H, Hoffmann D, Struve M, Diesch E: Auditory discrimination training for the treatment of tinnitus. Appl Psychophysiol Biofeedback 2004, 29: 113–120.CrossRefPubMed
19.
Bessman P, Heider T, Watten VP, Watten RG: The tinnitus intensive therapy habituation program: a 2-year follow-up pilot study on subjective tinnitus. Rehabil Psychol 2009, 54: 133–137.CrossRefPubMed
20.
Frank E, Schecklmann M, Landgrebe M, Burger J, Kreuzer P, Poeppl TB, Kleinjung T, Hajak G, Langguth B: Treatment of chronic tinnitus with repeated sessions of prefrontal transcranial direct current stimulation: outcomes from an open-label pilot study. J Neurol 2011, 259: 327–333.CrossRefPubMed
21.
de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM: Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health and Quality of Life Outcomes 2006, 4: 54. 10.1186/1477-7525-4-54PubMedCentralCrossRefPubMed
22.
Jacobson NS, Truax P: Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991, 59: 12–19.CrossRefPubMed
23.
Jacobson NS, Roberts LJ, Berns SB, McGlinchey JB: Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives. J Consult Clin Psychol 1999, 67: 300–307.CrossRefPubMed
24.
Altman DG: Practical Statistics For Medical Research. Chapman and Hal 1991.
25.
King MT: A point of minimal important difference (MID): a critique of terminology and methods. Expert Review of Pharmacoeconomics & Outcomes Research 2011, 11: 171–184. 10.1586/erp.11.9CrossRef
26.
Jaeschke R, Singer J, Guyatt GH: Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989, 10: 407–415.CrossRefPubMed
27.
Cohen J: Statistical power analysis for the behavioral sciences. L. Erlbaum Associates 1988.
28.
Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD: Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999, 37: 469–478. 10.1097/00005650-199905000-00006CrossRefPubMed
29.
Beaton DE, Boers M, Wells GA: Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol 2002, 14: 109–114. 10.1097/00002281-200203000-00006CrossRefPubMed
30.
Crosby RD, Kolotkin RL, Williams GR: Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003, 56: 395–407. 10.1016/S0895-4356(03)00044-1CrossRefPubMed
31.
Zeman F, Koller M, Figueiredo R, Aazevedo A, Rates M, Coelho C, Kleinjung T, de Ridder D, Langguth B, Landgrebe M: Tinnitus handicap inventory for evaluating treatment effects: which changes are clinically relevant? Otolaryngol Head Neck Surg 2011, 145: 282–287. 10.1177/0194599811403882CrossRefPubMed
32.
Suckfull M, Althaus M, Ellers-Lenz B, Gebauer A, Gortelmeyer R, Jastreboff PJ, Moebius HJ, Rosenberg T, Russ H, Wirth Y, Krueger H: A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus. BMC Ear Nose Throat Disord 2011, 11: 1. 10.1186/1472-6815-11-1PubMedCentralCrossRefPubMed
33.
Coelho C, Figueiredo R, Frank E, Burger J, Schecklmann M, Landgrebe M, Langguth B, Elgoyhen AB: Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study. Audiol Neurootol 2012, 17: 179–188. 10.1159/000335657CrossRefPubMed
34.
Wheaton L, Pope J: The Minimally Important Difference for Patient-reported Outcomes in Spondyloarthropathies including Pain, Fatigue, Sleep, and Health Assessment Questionnaire. J Rheumatol 2010, 37: 816–822. 10.3899/jrheum.090086CrossRefPubMed
35.
Busner J, Targum SD: The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 2007, 4: 28–37.
36.
Yost KJ, Eton DT: Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Eval Health Prof 2005, 28: 172–191. 10.1177/0163278705275340CrossRefPubMed
37.
Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE: Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 2002, 24: 547–561. 10.1016/S0885-3924(02)00529-8CrossRefPubMed
38.
Kelly A-M: The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emergency Medicine Journal 2001, 18: 205–207. 10.1136/emj.18.3.205PubMedCentralCrossRefPubMed
39.
Hagg O, Fritzell P, Nordwall A: The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 2003, 12: 12–20.PubMed
40.
Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM: Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001, 94: 149–158. 10.1016/S0304-3959(01)00349-9CrossRefPubMed
41.
Cella D, Hahn EA, Dineen K: Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Qual Life Res 2002, 11: 207–221. 10.1023/A:1015276414526CrossRefPubMed
42.
Landgrebe M, Zeman F, Koller M, Eberl Y, Mohr M, Reiter J, Staudinger S, Hajak G, Langguth B: The Tinnitus Research Initiative (TRI) database: a new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcome. BMC Med Inform Decis Mak 2010, 10: 42. 10.1186/1472-6947-10-42PubMedCentralCrossRefPubMed
43.
Tass PA, Adamchic I, Freund HJ, von Stackelberg T, Hauptmann C: Counteracting tinnitus by acoustic coordinated reset neuromodulation. Restorative Neurology and Neuroscience 2012, 30: 137–159.PubMed
44.
Adamchic I, Langguth B, Hauptmann C, Tass PA: Psychometric evaluation of Visual Analog Scale for the assessment of chronic tinnitus. Am J Audiol 2012. in press
45.
Revicki D, Hays RD, Cella D, Sloan J: Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008, 61: 102–109. 10.1016/j.jclinepi.2007.03.012CrossRefPubMed
46.
Fawcett T: An introduction to ROC analysis. Pattern Recognition Letters 2006, 27: 861–874. 10.1016/j.patrec.2005.10.010CrossRef
47.
Hauser RA, Auinger P: Determination of minimal clinically important change in early and advanced Parkinson's disease. Mov Disord 2011, 26: 813–818. 10.1002/mds.23638CrossRefPubMed
48.
Stratford PW, Binkley JM, Riddle DL, Guyatt GH: Sensitivity to change of the Roland-Morris back pain questionnaire: Part 1. Phys Ther 1998, 78: 1186–1196.PubMed
49.
Norman GR, Sloan JA, Wyrwich KW: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003, 41: 582–592.PubMed
50.
Norman GR, Stratford P, Regehr G: Methodological problems in the retrospective computation of responsiveness to change: The lesson of Cronbach. J Clin Epidemiol 1997, 50: 869–879. 10.1016/S0895-4356(97)00097-8CrossRefPubMed
51.
Redelmeier DA, Lorig K: Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology. Arch Intern Med 1993, 153: 1337–1342. 10.1001/archinte.1993.00410110045008CrossRefPubMed
52.
Wells GA, Tugwell P, Kraag GR, Baker PRA, Groh J, Redelmeier DA: Minimum Important Difference between Patients with Rheumatoid-Arthritis - the Patients Perspective. J Rheumatol 1993, 20: 557–560.PubMed
53.
Kleinjung T, Steffens T, Sand P, Murthum T, Hajak G, Strutz J, Langguth B, Eichhammer P: Which tinnitus patients benefit from transcranial magnetic stimulation? Otolaryngol Head Neck Surg 2007, 137: 589–595. 10.1016/j.otohns.2006.12.007CrossRefPubMed
54.
McHorney CA, Tarlov AR: Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995, 4: 293–307. 10.1007/BF01593882CrossRefPubMed
55.
Goebel G, Kahl M, Arnold W, Fichter M: 15-year prospective follow-up study of behavioral therapy in a large sample of inpatients with chronic tinnitus. Acta Otolaryngol Suppl 2006, 556: 70–79.CrossRefPubMed
56.
Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL: Defining the clinically important difference in pain outcome measures. Pain 2000, 88: 287–294. 10.1016/S0304-3959(00)00339-0CrossRefPubMed
Metadata
Title
Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: Which differences are clinically important?
Authors
Ilya Adamchic
Peter Alexander Tass
Berthold Langguth
Christian Hauptmann
Michael Koller
Martin Schecklmann
Florian Zeman
Michael Landgrebe
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2012
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-10-79

Other articles of this Issue 1/2012

Health and Quality of Life Outcomes 1/2012 Go to the issue

Research

Identification of aspects of functioning, disability and health relevant to patients experiencing vertigo: a qualitative study using the international classification of functioning, disability and health

Research

Health-related quality of life in family members of patients with an advanced cancer diagnosis: A one-year prospective study

Research

The effect of empowerment on the self-efficacy, quality of life and clinical and laboratory indicators of patients treated with hemodialysis: a randomized controlled trial

Research

Quality of life among tuberculosis (TB), TB retreatment and/or TB-HIV co-infected primary public health care patients in three districts in South Africa

Research

A cross-sectional survey of quality of life in colostomates: a report from Iran

Research

Experiences of patients with chronic gastrointestinal conditions: in their own words